| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
1 |
| mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.0027 |
1 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
1 |